Guided Therapeutics (GTHP) Total Debt (2011 - 2025)
Guided Therapeutics recorded quarterly Total Debt of $60000.0 in Q4 2025, down 44.44% quarter-over-quarter from $108000.0 in Q3 2025, and down 63.64% year-over-year from $165000.0 in Q4 2024.
Guided Therapeutics' Total Debt history runs 14 years deep, the most recent figure standing at $60000.0 for Q4 2025.
- In Q4 2025, Total Debt fell 63.64% year-over-year to $60000.0; the TTM figure through Dec 2025 stood at $60000.0 (down 63.64% YoY), while the FY2025 annual figure was $60000.0, down 63.64% from the prior year.
- Total Debt came in at $60000.0 for Q4 2025 at Guided Therapeutics, down from $108000.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $1.2 million in Q2 2024 to a low of $32000.0 in Q3 2022.
- A 4-year average of $360800.0 and a median of $110000.0 in 2021 frame the typical range for Total Debt.
- Across the five-year window, Total Debt jumped 1674.0% in 2021 and plunged 94.7% in 2022, its largest moves.
- Guided Therapeutics' Total Debt stood at $110000.0 in 2021, then slipped by 9.09% to $100000.0 in 2022, then surged by 65.0% to $165000.0 in 2024, then tumbled by 63.64% to $60000.0 in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $60000.0, $108000.0, and $95000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 28.07 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.93 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 108,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 107,000.00 |
| Dec 31, 2024 | 165,000.00 |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 32,000.00 |
| Jun 30, 2022 | 126,000.00 |
| Mar 31, 2022 | 595,000.00 |
| Dec 31, 2021 | 110,000.00 |
| Sep 30, 2021 | 604,000.00 |
| Jun 30, 2021 | 887,000.00 |
| Mar 31, 2021 | 51,000.00 |
| Dec 31, 2020 | 328,000.00 |
| Sep 30, 2020 | 592,000.00 |
| Jun 30, 2020 | 50,000.00 |
| Mar 31, 2020 | 577,000.00 |
| Dec 31, 2019 | 569,000.00 |
| Sep 30, 2019 | 1.06 Mn |
| Jun 30, 2019 | 552,000.00 |
| Mar 31, 2019 | 308,000.00 |
| Dec 31, 2018 | 340,000.00 |
| Sep 30, 2018 | 606,000.00 |
| Dec 31, 2017 | 1.09 Mn |
| Mar 31, 2017 | 651,000.00 |
| Dec 31, 2016 | 1.66 Mn |
| Sep 30, 2016 | 652,000.00 |
| Dec 31, 2015 | 815,000.00 |
| Jun 30, 2015 | 1.03 Mn |
| Mar 31, 2015 | 168,000.00 |
| Dec 31, 2014 | 163,000.00 |
| Sep 30, 2014 | 158,000.00 |
| Jun 30, 2014 | 164,000.00 |
| Mar 31, 2014 | 210,000.00 |
| Dec 31, 2013 | 212,000.00 |
| Sep 30, 2013 | 242,000.00 |
| Jun 30, 2013 | 258,000.00 |
| Mar 31, 2013 | 100,000.00 |
| Dec 31, 2012 | 4,000.00 |
| Sep 30, 2012 | 11,000.00 |
| Jun 30, 2012 | 17,000.00 |
| Mar 31, 2012 | 24,000.00 |
| Dec 31, 2011 | 25,000.00 |
| Jun 30, 2011 | 24,000.00 |